Summary The oestrogen receptor (ER) is considered to be an essential component of the mechanism of response of a breast tumour to endocrine therapy, but ER measurements have proved to have only modest predictive value. In the present study, we have examined ER status by both immunocytochemical assay (ER-ICA) on a fine needle aspirate and by radioligand-binding assay (DCC) on an excised portion of tumour.
enzyme-immuno assay (ER-EIA). Using these methods, it has been demonstrated that areas of individual tumours may be heterogeneous for oestrogen receptor expression (Hawkins et al., 1980; Crawford et al., 1987) as may individual lesions in patients with metastatic disease (Hawkins et al., 1981; King et al., 1982) , so diminishing the ability of biochemical assays to predict the overall response to endocrine therapy. Biochemical assay of tumour cytosols fails to give any information about the cellularity of the lesion or the distribution of the oestrogen receptors at a cellular level. However, by using the immunocytochemical assay (ER-ICA), the localisation and degree of receptor expression can be examined and we have previously demonstrated the importance of heterogeneity in determining whether a patient with a receptor-positive tumour will benefit from treatment with tamoxifen (Gaskell et al., 1989) . This assay provides two separate pieces of information, namely the intensity of staining and the proportion of cells stained. In the present paper, we have examined the significance of each of these factors in relation to the biochemical assay and to patient age. .
Methods
All patients underwent fine needle aspiration for diagnosis (Dixon et al., 1984) and the immunocytochemical assay was carried out on cytospin preparations of the remaining material, as we have described previously (Hawkins et al., 1988 (Snedecor, 1952) considering the two observers' scores as duplicates; for percentage cells stained and intensity of staining it was 19.6% and 17.2% respectively (n = 189, data not shown).
The tumours removed surgically were placed on ice and representative portions were selected by the pathologist for biochemical assay. The assays were carried out using our standard dextran-coated charcoal assay (DCC) for oestrogen receptors, based on competitive binding of a radioligand (tritiated oestradiol) and Scatchard analysis of the results (Hawkins et al., 1975 (Hawkins et al., , 1981 Relationship of ER-ICA staining to ER concentration by DCC assay Twenty-seven of 137 tumours were found to be oestrogen receptor-negative when assayed by the DCC assay. Similarly, 40/189 tumours assayed by the ER-ICA assay showed no evidence of immunocytochemical staining for oestrogen receptor protein. When the results obtained by the immunocytochemical assay were compared with the oestrogen receptor concentrations as determined by DCC, there was a good correlation between the results of theDCC assay and the observed intensity of staining (Spearman's Rank correlation coefficient 0.77, P<0.0001, n = 137). When the tumours considered to be oestrogen receptor-positive (by DCC) were considered separately the correlation was maintained, though slightly less strongly (Spearman's Rank correlation coefficient 0.59, P <0.0001, n = 108). The second parameter, the percentage of cells staining, correlated less strongly with the results of the DCC assay (Spearman's Rank correlation coefficient 0.70, P<0.0001; for ER + ve tumours only, Spearman's Rank correlation coefficient 0.47, P <0.001, n = 108)). This correlation was not strengthened by combining the two parameters (% cells stained x intensity of staining) to produce a staining index (Spearman's Rank correlation coefficients 0.71, P<0.0001, n = 108 and 0.51, P<0.0001, n = 108 respectively).
Relationship between patient age and the ER status (DCC and ER-ICA) The proportion of oestrogen receptor-negative tumours (as measured by DCC assay) fell steadily with increasing age (Table I ). There was a correlation between the median age of the women with oestrogen-positive breast cancers, when they were grouped by decade and the oestrogen receptor concentrations measured in their tumours (Spearman's Rank correlation coefficient 0.39, P<0.0001, n = 108, Figure 1) . Similarly, the proportion of tumours failing to show immunocytochemical staining for oestrogen receptor protein fell with increasing age (Table I) . Figures 2 and 3 show the relationship between the patient's age and the results of the ER-ICA assay. The intensity of staining correlated moderately well with increasing age (Spearman's Rank correlation coefficient 0.26, P = 0.0001, n = 149), but for the oestrogen receptor-positive (staining) tumours the percentage of cells stained did not alter significantly with age (Spearman's Rank correlation coefficients 0.08, P = not significant). 
Discussion
Inter-relationships between the assays (Table II) In the present study, we found that each of the parameters of the ER-ICA assay (percentage cells stained, staining intensity and staining index) showed a good correlation with the results of the biochemical assay. However, three of 29 tumours showing no biochemical evidence of ER-protein showed some immunocytochemical staining and conversely -protein (McCarty et al., 1986; Charpin et al., 1986; Hawkins et al., 1986; Reiner et al., 1986; Weintraub et al., 1987; Horsfall et al., 1989) .
Relationships of the assays to age In agreement with earlier workers (Allegra et al., 1979; Beex & Koenders, 1984; Merecki & Jordan, 1985) , (Gaskell et al., 1989) , it was the intensity of staining which had the better correlation with age (Spearman's Rank correlation coefficient 0.26, P = 0.001, n = 149). These findings suggest that the two components of the ER-ICA assay differ in their significance. As the patients get older, the numbers of receptors per cell (intensity of staining) increases, as reflected in the increase in biochemically detected ER concentration with age. Distribution of receptor (% cells stained), however, failed to correlate with age and in our experience and that of other investigators, this is the critical factor in response to endocrine therapy (Pertschuk et al., 1985 , Coombes et al., 1987 , Gaskell et al., 1989 . Our findings may therefore help to explain the difficulties experienced in relating clinical outcome to the absolute oestrogen receptor concentration as measured biochemically in cytosolbased assays (Howat et al., 1983) . Tumours containing only a small proportion of cells which stain intensely for ER protein may prove to be relatively resistant to endocrine therapy despite high concentrations of ER protein being detected biochemically; biochemical assays do not take account of tumour cellularity and heterogeneity, as indicated previously by Horsfall et al. (1989) using video image analysis of the nuclear optical densities.
Conclusion
These data may help to explain why apparently oestrogen receptor-rich breast cancers can fail to respond to endocrine therapy. It is the number of receptors per cell (as indicated by the intensity of staining) which (i) correlates best with the biochemically measured oestrogen receptor level and (ii) changes most with age. However, it is the number (proportion) of receptor-positive cells in a tumour which determines the likelihood of response. This has particular implications for the elderly, where some very high oestrogen receptor concentrations detected biochemically may be of no greater clinical significance than moderate levels detected in younger women.
